Utilizing sequences identified via yeast display selections, investigators trained prediction algorithms and identifed human and cytomegalovirus proteome-derived, HLA-E-presented peptides capable of binding and signaling through both CD94/NKG2A and CD94/NKG2C.
[Nature Communications]